+44-1518081136Clinical Trials and Pharmacovigilance
September 23-24, 2019 | Prague, Czech Republic
Posters & Accepted Abstracts
-
Alopurinol-induced TEN and association with HLA B*58:01 in white patients
J Clin Res Pharm
Fabrizzio P Saavedraa, Alberto S Garciab, Enrique S Gonzalezb and Luis C L Romeroa -
Do hand functions effect in male patients with ankylosing spondylitis?
J Clin Res Pharm
Oguzhan Mete, Songul Baglan Yentur, Devrim Can Sarac, Fulden Sari, Gizem Tore, Hakan Babaoglu, Mehmet Akif Ozturk, Deran Oskay -
Efficacy of N-SORB® a proprietary KD120 MEC metabolically activated enzyme formulation: A randomized, double-blind, placebo-controlled study
J Clin Res Pharm
Rui Guo, Sreejayan Nair, Derek Smith, Bledar Bisha, Rama Nair, Bernard W Downs, Steve Kushner, Debasis Bagchi and Manashi Bagchi -
Inactivity behavior and exercise barriers in patients with Behcet disease
J Clin Res Pharm
Songul Baglan Yentur, Devrim Can Sarac, Fulden Sari, Gizem Tore, Nuh Atas, Mehmet Akif Ozturk and Deran Oskay -
Relationship between thoracic kyphosis and shoulder muscle strength and shoulder joint motion in male patients with ankylosing spondylitis
J Clin Res Pharm
Oguzhan Mete, Devrim Can Sarac, Songul Baglan Yentur, Gizem Tore, Fulden Sari, Nuh Atas, Berna Goker and Deran Oskay -
Understanding of clinical investigator about the serious adverse event reporting and its complexity in Latin America
J Clin Res Pharm
Carmela Gelida Barboza Justiniano -
Weekly cabazitaxel in elderly patients (EP) with metastatic castration resistant prostate cancer (mCRPC) progressing after docetaxel treatment: WeCabE, a phase II study
J Clin Res Pharm
A Bruno Castagneto and B Ilaria Stevani